Entity family
Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.
Showing 7,681–7,740 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
…static chemotherapy-naive castration-resistant prostate cancer. J Clin Oncol. 2017;35:40–7.Powles T, Yuen KC, Gillessen S, Kadel EE, Rathkop…
…eca Human Biological Sample global standard and approved by the HBS regulatory board. All samples used for these work were collected from patients t…
…ens and information was approved by the Ethics Committee of the Tianjin Medical University Cancer Institute and Hospital (Approve number: bc2022323). All animal experiments were perfor…
…udy was approved by the Ethics Committee of Zhongshan Hospital, Fudan University (IRB number: B2021-464).Consent Written informed consent was ob…
…ethics committees of Sir Run Run Shaw Hospital, affiliated with Zhejiang University School of Medicine. The ID of the approval is 2023-0465. Written informed consent …
…number: NCT06865521).All patients were recruited and treated at West China Hospital of Sichuan University, where the study protocol was approved by the Institutional Rev…
…umber: NCT06865521). All patients were recruited and treated at West China Hospital of Sichuan University, where the study protocol was approved by the Institutional Rev…
…23;29(2):458–466.Ethics Approval This study was approved by the DF/HCC IRB as protocol 18-144 (see also ClinicalTrials.gov NCT03668431).…
…elial barrier, potentially synergizing with PD-L1 blockade. The EORTC-1508GCG phase II trial evaluated atezolizumab (anti-PD-L1), bevacizumab…
…00 (EudraCT 2018-003267-58) Initial approval on 26 Mar 2020 US: Mayo Clinic Institutional Review Boards ID: 20-007421 Initial approval on 1…
…checkpoint inhibitor.Methods In this single-arm phase 1 trial ( NCT05025800), adult patients with relapsed indolent B-NHL received evorpace…
…view Board (IRB # AAAS9173). The study was also approved by the Memorial Sloan Kettering Cancer Center Institutional Review Board (IRB protocol number: 21-519).Abstract 516 Figure 1Tocilizumab …